Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
health
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
abbvie
acorda therapeutics
alder biopharmaceuticals
amgen
ampyra
apokyn
apomorphine
author_name|malak saleh
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
dalfampridine
david rind
detroit blog main
detroit top stories
digital therapeutics
disease & medical conditions
duopa
eli lilly
episodic migraine
eptinezumab
erenumab
fda
food and drug administration
fremanezumab
galcanezumab
health care industry
inbrija
indiana blog main
What
fda
5
×
gets
5
×
new
5
×
approval
developed
drug
failure
heart
medical
nod
patients
treatments
acorda
amgen
announced
app
approved
arm
atrial
based
biofourmis
biosense
boston
breakthrough
candidates
cause
class
clinical
closer
company
condition
conduct
cope
designation
device
digital
disease
elon
episodes
fibrillation
Language
unset
Current search:
gets
×
new
×
photo
×
fda
×
@engadget.com
9 months ago
Johnson & Johnson gets FDA approval for heart treatments that don't require X-rays
@slashgear.com
11 months ago
Elon Musk's Neuralink Finally Gets FDA Approval For Human Testing
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines